Replies to post #10385 on Medicine Man Technologies Inc (SHWZ)

[Future2016]

“$SHWZ strong 21 guidance: $105-125m rev $28-36m aEBITDA 26.7-28.8%mgn, inline to ahead of my est $109m & $28m first published on 1/4/21 @mjresearchco. midpoint EV/S=2.8X EV/EBITDA=10.2X. contd execution = key. disclosure long $SHWZ not investment advice”

“my $SHWZ initiation Oct 2020 @mjresearchco is now publicly available. overall narrative is the same: close Starbuds, expand margins, consolidate Colorado. targets = stale, ests&shs??do your own due diligence. disclosure I'm long $SHWZ not investment advice”

- Mike Regan, founder and analyst at MJ Research Co & regular contributor to MJ Biz Daily

$SHWZ strong 21 guidance: $105-125m rev $28-36m aEBITDA 26.7-28.8%mgn, inline to ahead of my est $109m & $28m first published on 1/4/21 @mjresearchco. midpoint EV/S=2.8X EV/EBITDA=10.2X. contd execution = key. disclosure long $SHWZ not investment advice https://t.co/MjKae1DhtD pic.twitter.com/wD2ZPKrcIr

— Mike Regan (@MikeReganInvest) March 30, 2021